カテゴリー： 世界, 医療/バイオ, Research Dive

世界の凝固検査市場2022年-2031年：製品種類別（器具、消耗品）、用途別（プロトロンビン時間、活性化部分トロンボプラスチン時間、トロンビン時間、活性化凝固時間）、エンドユーザー別（病院、臨床検査室、ポイントオブケア検査、その他）、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）

【英語タイトル】Coagulation Testing Market by Product Type (Instruments, Consumables), Application (Prothrombin Time, Activated Partial Thromboplastin Time, Thrombin Time, Activated Clotting Time), End User (Hospitals, Clinical Laboratories, Point-of-Care Testing, Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2031

Research Diveが出版した調査資料（RDV23MA017）・商品コード：RDV23MA017
・発行会社（調査会社）：Research Dive
・発行日：2022年12月27日
・ページ数：260
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：生命科学
◆販売価格オプション（消費税別）
Single UserUSD5,700 ⇒換算￥866,400見積依頼/購入/質問フォーム
5 UserUSD8,700 ⇒換算￥1,322,400見積依頼/購入/質問フォーム
Enterprise UserUSD10,700 ⇒換算￥1,626,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Research Dive社の本調査レポートでは、世界の凝固検査市場規模が2021年3,101.7百万ドルから2031年には8,777.3百万ドルに達し、年平均11.5%成長すると予測しています。本レポートは、凝固検査の世界市場について調査を行い、調査手法、調査範囲、エグゼクティブサマリー、市場概要、製品種類別（器具、消耗品）分析、用途別（プロトロンビン時間、活性化部分トロンボプラスチン時間、トロンビン時間、活性化凝固時間）分析、エンドユーザー別（病院、臨床検査室、ポイントオブケア検査、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況などの項目をまとめています。なお、企業情報には、Thermo Fisher Scientific Inc., Helena Laboratories Corporation., Micropoint Biosciences, Medtronic, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation., Abbott., Sysmex Corporation, BD Biosciences., and Danaher.などが含まれています。
・調査手法
・調査範囲
・エグゼクティブサマリー
・市場概要
・世界の凝固検査市場規模：製品種類別
- 器具の市場規模
- 消耗品の市場規模
・世界の凝固検査市場規模：用途別
- プロトロンビン時間における市場規模
- 活性化部分トロンボプラスチン時間における市場規模
- トロンビン時間における市場規模
- 活性化凝固時間における市場規模
・世界の凝固検査市場規模：エンドユーザー別
- 病院における市場規模
- 臨床検査室における市場規模
- ポイントオブケア検査における市場規模
- その他エンドユーザーにおける市場規模
・世界の凝固検査市場規模：地域別
- 北米の凝固検査市場規模
- ヨーロッパの凝固検査市場規模
- アジア太平洋の凝固検査市場規模
- 中南米の凝固検査市場規模
- 中東/アフリカの凝固検査市場規模
・競争状況
・企業情報

According to Research Dive analysis, the global coagulation testing market is anticipated to generate revenue of $8,777.3 million by 2031, increasing from $3,101.7 million in 2021, at a healthy CAGR of 11.5%.

COVID-19 Impact on the Global Coagulation Testing Market:

The COVID-19 pandemic has resulted in serious disruptions that have impacted many companies and disrupted demand, supply, and import-export around the world. There were limitations such as lockdowns and quarantines that stopped people from traveling outside. The COVID-19 event has positively impacted the global coagulation testing market owing to the growing prevalence of heart disorders and the rise in COVID-19 cases which has increased the demand for blood tests globally. Many studies are focused on identifying the behavior of coagulopathy connected with the novel coronavirus. It was revealed that patients who had more D-dimer are more vulnerable to serious complications. Many of government authorities are adopting different steps to help the companies maintain operations throughout the coronavirus epidemic. Furthermore, the government has planned to boost innovations in areas including telemedicine, life science, pharmaceutical and healthcare industries.

Coagulation Testing Market Analysis:

Modern technologies, including microfluidics, and electrochemical sensing are used to construct point-of-care (POC) devices. The rise in cardiovascular issues and chronic blood illnesses will promote global market expansion. There is a rise in geriatric population, high demand for point-of-care coagulation testing, and technological advancements such as faster and easier-to-use devices with advanced sensor technology. Availability of advanced coagulation testing kits, with the ability to conduct tests with high accuracy is another major driving factor. Favorable government policies favoring the best healthcare delivery in several regions is promoting the use of such kits.
The costs associated with tests and treatment which limits its usage to only the population which is economically capable gives a negative impact on the global coagulation testing market. Numerous studies have concluded that Point-of-Care Coagulation Testing (POCCT) findings are less trustworthy than test results from central laboratories, which further calls into question the business viability of these devices. There is a slight possibility of having slight soreness or bruises at the site and risks of lightheadedness, pain, and infection.

There are continuous technological advancements that are propelling the market growth, such as smartphone-enabled coagulation test. For instance, a team of researchers in Switzerland developed a smartphone-based coagulation test to help patients on anticoagulation therapy self-test at home. This new smartphone device would enable patients to monitor their blood flow at home or anywhere. It would also speed delivery of the test results to attending physicians. Furthermore, the University of Washington has developed a test to assess blood clotting that uses a single drop of blood and a smartphone vibration motor and camera.
Based on product, the consumables sub-segment is predicted to show the fastest growth during the forecast period. This is primarily due to the increased availability of over-the-counter tests, easy availability of coagulation solutions at affordable prices, and high investments from the private sector.
Based on application, prothrombin time sub-segment accounted for the highest revenue share because it is used to measure patients’ chronic atrial fibrillation and venous embolism.
Based on end user, the point-of-care testing sub-segment is predicted to show the fastest growth during the forecast period. This is because point-of-care tests provide results in real-time, rather than in hours or days, which aids in taking decisions about medical care faster.
Based on geographical scope, the Europe coagulation testing market is anticipated to rise at a growth rate of 11.6% by 2031 from the revenue generated in 2021. This growth would be a result of increased investment in healthcare facilities and a rise in the geriatric population.
The companies involved in the global coagulation testing market are some of the significant coagulation testing market players, including Thermo Fisher Scientific Inc., Helena Laboratories Corporation., Micropoint Biosciences, Medtronic, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation., Abbott., Sysmex Corporation, BD Biosciences., and Danaher.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation

1.5.1.Top-down approach
1.5.2.Bottom-up approach

2.Report Scope

2.1.Market definition
2.2.Key objectives of the study
2.3.Report overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on Global Coagulation Testing Market

3.Executive Summary

4.Market Overview

4.1.Introduction
4.2.Growth impact forces

4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities

4.3.Market value chain analysis

4.3.1.List of component suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors

4.4.Innovation & sustainability matrices

4.4.1.Technology matrix
4.4.2.Regulatory matrix

4.5.Porter’s five forces analysis

4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity

4.6.PESTLE analysis

4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.Environmental

4.7.Impact of COVID-19 on Coagulation Testing Market

4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario

5.Coagulation Testing Market Analysis, by Product

5.1.Overview

5.2.Instruments

5.2.1.Definition, key trends, growth factors, and opportunities, 2022-2031
5.2.2.Market size analysis, by region, 2022-2031
5.2.3.Market share analysis, by country, 2022-2031

5.3.Consumables

5.3.1.Definition, key trends, growth factors, and opportunities, 2022-2031
5.3.2.Market size analysis, by region, 2022-2031
5.3.3.Market share analysis, by country, 2022-2031

5.4.Research Dive Exclusive Insights

5.4.1.Market attractiveness
5.4.2.Competition heatmap

6.Coagulation Testing Market Analysis, by Application

6.1.Prothrombin Time

6.1.1.Definition, key trends, growth factors, and opportunities, 2022-2031
6.1.2.Market size analysis, by region, 2022-2031
6.1.3.Market share analysis, by country, 2022-2031

6.2.Activated Partial Thromboplastin Time

6.2.1.Definition, key trends, growth factors, and opportunities, 2022-2031
6.2.2.Market size analysis, by region, 2022-2031
6.2.3.Market share analysis, by country, 2022-2031

6.3.Thrombin Time

6.3.1.Definition, key trends, growth factors, and opportunities, 2022-2031
6.3.2.Market size analysis, by region, 2022-2031
6.3.3.Market share analysis, by country, 2022-2031

6.4.Activated Clotting Time

6.4.1.Definition, key trends, growth factors, and opportunities, 2022-2031
6.4.2.Market size analysis, by region, 2022-2031
6.4.3.Market share analysis, by country, 2022-2031

6.5.Research Dive Exclusive Insights

6.5.1.Market attractiveness
6.5.2.Competition heatmap

7.Coagulation Testing Market Analysis, by End User

7.1.Hospitals

7.1.1.Definition, key trends, growth factors, and opportunities, 2022-2031
7.1.2.Market size analysis, by region, 2022-2031
7.1.3.Market share analysis, by country, 2022-2031

7.2.Clinical Laboratories

7.2.1.Definition, key trends, growth factors, and opportunities, 2022-2031
7.2.2.Market size analysis, by region, 2022-2031
7.2.3.Market share analysis, by country, 2022-2031

7.3.Point-of-Care Testing

7.3.1.Definition, key trends, growth factors, and opportunities, 2022-2031
7.3.2.Market size analysis, by region, 2022-2031
7.3.3.Market share analysis, by country, 2022-2031

7.4.Others

7.4.1.Definition, key trends, growth factors, and opportunities, 2022-2031
7.4.2.Market size analysis, by region, 2022-2031
7.4.3.Market share analysis, by country, 2022-2031

7.5.Research Dive Exclusive Insights

7.5.1.Market attractiveness
7.5.2.Competition heatmap

8.Coagulation Testing Market, by Region

8.1.North America

8.1.1.U.S.

8.1.1.1.Market size analysis, by Product, 2022-2031
8.1.1.2.Market size analysis, by Application, 2022-2031
8.1.1.3.Market size analysis, by End User, 2022-2031

8.1.2.Canada

8.1.2.1.Market size analysis, by Product, 2022-2031
8.1.2.2.Market size analysis, by Application, 2022-2031
8.1.2.3.Market size analysis, by End User, 2022-2031

8.1.3.Mexico

8.1.3.1.Market size analysis, by Product, 2022-2031
8.1.3.2.Market size analysis, by Application, 2022-2031
8.1.3.3.Market size analysis, by End User, 2022-2031

8.1.4.Research Dive Exclusive Insights

8.1.4.1.Market attractiveness
8.1.4.2.Competition heatmap

8.2.Europe

8.2.1.Germany

8.2.1.1.Market size analysis, by Product, 2022-2031
8.2.1.2.Market size analysis, by Application, 2022-2031
8.2.1.3.Market size analysis, by End User, 2022-2031

8.2.2.UK

8.2.2.1.Market size analysis, by Product, 2022-2031
8.2.2.2.Market size analysis, by Application, 2022-2031
8.2.2.3.Market size analysis, by End User, 2022-2031

8.2.3.France

8.2.3.1.Market size analysis, by Product, 2022-2031
8.2.3.2.Market size analysis, by Application, 2022-2031
8.2.3.3.Market size analysis, by End User, 2022-2031

8.2.4.Spain

8.2.4.1.Market size analysis, by Product, 2022-2031
8.2.4.2.Market size analysis, by Application, 2022-2031
8.2.4.3.Market size analysis, by End User, 2022-2031

8.2.5.Italy

8.2.5.1.Market size analysis, by Product, 2022-2031
8.2.5.2.Market size analysis, by Application, 2022-2031
8.2.5.3.Market size analysis, by End User, 2022-2031

8.2.6.Rest of Europe

8.2.6.1.Market size analysis, by Product, 2022-2031
8.2.6.2.Market size analysis, by Application, 2022-2031
8.2.6.3.Market size analysis, by End User, 2022-2031

8.2.7.Research Dive Exclusive Insights

8.2.7.1.Market attractiveness
8.2.7.2.Competition heatmap

8.3.Asia-Pacific

8.3.1.China

8.3.1.1.Market size analysis, by Product, 2022-2031
8.3.1.2.Market size analysis, by Application, 2022-2031
8.3.1.3.Market size analysis, by End User, 2022-2031

8.3.2.Japan

8.3.2.1.Market size analysis, by Product, 2022-2031
8.3.2.2.Market size analysis, by Application, 2022-2031
8.3.2.3.Market size analysis, by End User, 2022-2031

8.3.3.India

8.3.3.1.Market size analysis, by Product, 2022-2031
8.3.3.2.Market size analysis, by Application, 2022-2031
8.3.3.3.Market size analysis, by End User, 2022-2031

8.3.4.Australia

8.3.4.1.Market size analysis, by Product, 2022-2031
8.3.4.2.Market size analysis, by Application, 2022-2031
8.3.4.3.Market size analysis, by End User, 2022-2031

8.3.5.South Korea

8.3.5.1.Market size analysis, by Product, 2022-2031
8.3.5.2.Market size analysis, by Application, 2022-2031
8.3.5.3.Market size analysis, by End User, 2022-2031

8.3.6.Rest of Asia-Pacific

8.3.6.1.Market size analysis, by Product, 2022-2031
8.3.6.2.Market size analysis, by Application, 2022-2031
8.3.6.3.Market size analysis, by End User, 2022-2031

8.3.7.Research Dive Exclusive Insights

8.3.7.1.Market attractiveness
8.3.7.2.Competition heatmap

8.4.LAMEA

8.4.1.Brazil

8.4.1.1.Market size analysis, by Product, 2022-2031
8.4.1.2.Market size analysis, by Application, 2022-2031
8.4.1.3.Market size analysis, by End User, 2022-2031

8.4.2.Saudi Arabia

8.4.2.1.Market size analysis, by Product, 2022-2031
8.4.2.2.Market size analysis, by Application, 2022-2031
8.4.2.3.Market size analysis, by End User, 2022-2031

8.4.3.UAE

8.4.3.1.Market size analysis, by Product, 2022-2031
8.4.3.2.Market size analysis, by Application, 2022-2031
8.4.3.3.Market size analysis, by End User, 2022-2031

8.4.4.South Africa

8.4.4.1.Market size analysis, by Product, 2022-2031
8.4.4.2.Market size analysis, by Application, 2022-2031
8.4.4.3.Market size analysis, by End User, 2022-2031

8.4.5.Rest of LAMEA

8.4.5.1.Market size analysis, by Product, 2022-2031
8.4.5.2.Market size analysis, by Application, 2022-2031
8.4.5.3.Market size analysis, by End User, 2022-2031

8.4.6.Research Dive Exclusive Insights

8.4.6.1.Market attractiveness
8.4.6.2.Competition heatmap

9.Competitive Landscape

9.1.Top winning strategies, 2021

9.1.1.By strategy
9.1.2.By year

9.2.Strategic overview

9.3.Market share analysis, 2021

10.Company Profiles

10.1. Thermo Fisher Scientific Inc.

10.1.1.Overview
10.1.2.Business segments
10.1.3.Product portfolio
10.1.4.Financial performance
10.1.5.Recent developments
10.1.6.SWOT analysis

10.2.Helena Laboratories Corporation.

10.2.1.Overview
10.2.2.Business segments
10.2.3.Product portfolio
10.2.4.Financial performance
10.2.5.Recent developments
10.2.6.SWOT analysis

10.3.Micropoint Biosciences

10.3.1.Overview
10.3.2.Business segments
10.3.3.Product portfolio
10.3.4.Financial performance
10.3.5.Recent developments
10.3.6.SWOT analysis

10.4.Medtronic

10.4.1.Overview
10.4.2.Business segments
10.4.3.Product portfolio
10.4.4.Financial performance
10.4.5.Recent developments
10.4.6.SWOT analysis

10.5.Hoffmann-La Roche Ltd

10.5.1.Overview
10.5.2.Business segments
10.5.3.Product portfolio
10.5.4.Financial performance
10.5.5.Recent developments
10.5.6.SWOT analysis

10.6.NIHON KOHDEN CORPORATION

10.6.1.Overview
10.6.2.Business segments
10.6.3.Product portfolio
10.6.4.Financial performance
10.6.5.Recent developments
10.6.6.SWOT analysis

10.7.Sysmex Corporation

10.7.1.Overview
10.7.2.Business segments
10.7.3.Product portfolio
10.7.4.Financial performance
10.7.5.Recent developments
10.7.6.SWOT analysis

10.8.Abbott

10.8.1.Overview
10.8.2.Business segments
10.8.3.Product portfolio
10.8.4.Financial performance
10.8.5.Recent developments
10.8.6.SWOT analysis

10.9.BD Biosciences

10.9.1.Overview
10.9.2.Business segments
10.9.3.Product portfolio
10.9.4.Financial performance
10.9.5.Recent developments
10.9.6.SWOT analysis

10.10.Danaher

10.10.1.Overview
10.10.2.Business segments
10.10.3.Product portfolio
10.10.4.Financial performance
10.10.5.Recent developments
10.10.6.SWOT analysis



★調査レポート[世界の凝固検査市場2022年-2031年：製品種類別（器具、消耗品）、用途別（プロトロンビン時間、活性化部分トロンボプラスチン時間、トロンビン時間、活性化凝固時間）、エンドユーザー別（病院、臨床検査室、ポイントオブケア検査、その他）、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）] (コード：RDV23MA017)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の凝固検査市場2022年-2031年：製品種類別（器具、消耗品）、用途別（プロトロンビン時間、活性化部分トロンボプラスチン時間、トロンビン時間、活性化凝固時間）、エンドユーザー別（病院、臨床検査室、ポイントオブケア検査、その他）、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のAACブロック＆パネル市場2022年-2031年：製品種類別（ブロック、パネル、まぐさ、その他）、エンドユーザー別（住宅建設、商業建設、産業建設、インフラ建設）、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）
  • 世界の止血診断市場2023-2030：製品別（ラボラトリーアナライザー、ポイントオブケア検査システム）、検査種類別（活性化部分トロンボプラスチン時間、Dダイマー検査、フィブリノゲン検査、プロトロンビン時間検査、活性化凝固時間、血小板凝集検査）、エンドユーザー別（病院、診断センター、その他）、地域別
  • 世界の免税店市場2022年-2031年：製品種類別（香水&化粧品、電子機器、ワイン&スピリッツ、食品、菓子&ケータリング、タバコ、高級品、その他）、販売チャネル別（空港、クルーズ船、鉄道駅、国境、ダウンタウン&ホテルショップ）、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）
  • 世界の携帯用酸素キット市場2022年-2031年：エンドユーザー別（医療、家庭用、航空宇宙＆自動車、その他）、地域別（ヨーロッパ、北米、アジア太平洋、中南米・中東・アフリカ）
  • 世界のシルク市場2022年-2031年：種類別（マルベリーシルク、タッサーシルク、エリシルク、その他）、エンドユーザー別（テキスタイル、化粧品、医療）、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）
  • 世界のタンパク質アッセイ市場2023年-2032年：製品種類別（キット・試薬、機器・付属品）、技術別（吸光度ベースタンパクアッセイ、比色ベースタンパクアッセイ、蛍光ベースタンパクアッセイ）、用途別（創薬・開発、疾病診断）、エンドユーザー別（製薬・バイオテクノロジー企業、臨床検査室、その他）
  • 世界の車載音声コマンドシステム市場2022年-2031年：技術別（組み込み型、その他）、用途別（AI、非AI）、車両種類別（ICE、BEV）、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）
  • 世界の左心耳 (LAA) 閉鎖デバイス市場2022年-2031年：製品別（心外膜LAAデバイス、心内膜LAA閉鎖デバイス）、最終用途別（病院、外来手術センター、その他）、地域別（ヨーロッパ、北米、アジア太平洋、中南米・中東・アフリカ）

    • ◆H&Iグローバルリサーチのお客様（例）◆